Veterinary and Agrochemical Research Centre (CODA-CERVA), Coordination of Veterinary Diagnostics, Epidemiology and Risk Assessment (CVD-ERA), Groeselenberg 99, B-1180 Brussels, Belgium.
Prev Vet Med. 2012 Oct 1;106(3-4):235-43. doi: 10.1016/j.prevetmed.2012.03.011. Epub 2012 Apr 7.
Bluetongue virus serotype 8 (BTV-8) emerged in Central Western Europe in 2006 causing a large scale epidemic in 2007 that involved several European Union (EU) countries including Belgium. As in several other EU member states, vaccination against BTV-8 with inactivated vaccines was initiated in Belgium in spring 2008 and appeared to be successful. Since 2009, no clinical cases of Bluetongue (BT) have been reported in Belgium and BTV-8 circulation seemed to have completely disappeared by spring 2010. Therefore, a series of repeated cross-sectional surveys, the BT sentinel surveillance program, based on virus detection in blood samples by means of real-time RT-PCR (RT-qPCR) were carried out in dairy cattle from the end of 2010 onwards with the aim to demonstrate the absence of BTV circulation in Belgium. This paper describes the results of the first two sampling rounds of this BT sentinel surveillance program carried out in October-November 2010 and January-February 2011. In addition, the level of BTV-specific maternal antibodies in young non-vaccinated animals was monitored and the level of herd immunity against BTV-8 after 3 consecutive years of compulsory BTV-8 vaccination was measured by ELISA. During the 1st sampling round of the BT sentinel surveillance program, 15 animals tested positive and 2 animals tested doubtful for BTV RNA by RT-qPCR. During the 2nd round, 17 animals tested positive and 5 animals tested doubtful. The positive/doubtful animals in both rounds were re-sampled 2-4 weeks after the original sampling and then all tested negative by RT-qPCR. These results demonstrate the absence of BTV circulation in Belgium in 2010 at a minimum expected prevalence of 2% and 95% confidence level. The study of the maternal antibodies in non-vaccinated animals showed that by the age of 7 months maternal antibodies against BTV had disappeared in most animals. The BTV seroprevalence at herd level after 3 years of compulsory BTV-8 vaccination was very high (97.4% [95% CI: 96.2-98.2]). The overall true within-herd BTV seroprevalence in 6-24 month old Belgian cattle in early 2011 was estimated at 73.4% (95% CI: 71.3-75.4).
2006 年,8 型蓝舌病毒(BTV-8)在中欧西部出现,并于 2007 年在多个欧盟(EU)国家引发了大规模疫情,其中包括比利时。与其他几个欧盟成员国一样,2008 年春季比利时开始对 BTV-8 进行灭活疫苗接种,且效果似乎很好。自 2009 年以来,比利时未报告过蓝舌病(BT)临床病例,且 BTV-8 的传播似乎在 2010 年春季完全消失。因此,自 2010 年底以来,比利时开展了一系列重复的横断面调查,即 BT 哨点监测计划,该计划通过实时 RT-PCR(RT-qPCR)在奶牛血液样本中检测病毒,以证明比利时不存在 BTV 循环。本文描述了 2010 年 10 月至 11 月和 2011 年 1 月至 2 月开展的 BT 哨点监测计划的前两轮抽样结果。此外,还监测了未接种疫苗的幼畜中 BTV 特异性母源抗体的水平,并通过 ELISA 测量了 3 年连续 BTV-8 疫苗接种后的群体免疫力。在 BT 哨点监测计划的第一轮抽样中,15 只动物通过 RT-qPCR 检测为 BTV RNA 阳性,2 只动物检测结果为可疑。第二轮中,17 只动物检测结果为阳性,5 只动物检测结果为可疑。两轮中阳性/可疑动物在初次采样后 2-4 周重新采样,然后 RT-qPCR 检测结果均为阴性。这些结果表明,在 2010 年,比利时的 BTV 流行率预计至少为 2%,置信区间为 95%,且 BTV 不存在循环。对未接种疫苗的动物的母源抗体的研究表明,大多数动物在 7 月龄时已不再具有 BTV 抗体。3 年连续 BTV-8 疫苗接种后,群体的 BTV 血清阳性率非常高(97.4%[95%CI:96.2-98.2])。2011 年初,6-24 月龄的比利时牛的总体真群体 BTV 血清阳性率估计为 73.4%(95%CI:71.3-75.4)。